当前位置: 首页 >> 检索结果
共有 8124 条符合本次的查询结果, 用时 4.3163199 秒

7861. From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses.

作者: Lin-Fa Wang.;Danielle E Anderson.;John S Mackenzie.;Michael H Merson.
来源: Lancet. 2020年395卷10224期e33-e34页

7862. Early lessons from the frontline of the 2019-nCoV outbreak.

作者: Hong Zhang.
来源: Lancet. 2020年395卷10225期687页

7863. Ebola virus disease and breastfeeding.

作者: Anna E Thorson.;Megan Foeller.;Pura Rayco-Solon.;Zita Weise Prinzo.;João Paulo Souza.;Juan Pablo Peña-Rosas.
来源: Lancet. 2020年395卷10223期491页

7864. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial.

作者: .
来源: Lancet. 2020年395卷10225期698-708页
Observational studies have suggested that accelerated surgery is associated with improved outcomes in patients with a hip fracture. The HIP ATTACK trial assessed whether accelerated surgery could reduce mortality and major complications.

7865. Hip attack for hip fractures: is ultra-early surgery necessary?

作者: Alejandro Lizaur-Utrilla.;Fernando A Lopez-Prats.
来源: Lancet. 2020年395卷10225期661-662页

7866. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

作者: Clark D Russell.;Jonathan E Millar.;J Kenneth Baillie.
来源: Lancet. 2020年395卷10223期473-475页

7867. 2019-nCoV epidemic: address mental health care to empower society.

作者: Yanping Bao.;Yankun Sun.;Shiqiu Meng.;Jie Shi.;Lin Lu.
来源: Lancet. 2020年395卷10224期e37-e38页

7868. ECHO: context and limitations - Authors' reply.

作者: Jared M Baeten.;James Kiarie.;Timothy D Mastro.;Nelly R Mugo.;Helen Rees.; .
来源: Lancet. 2020年395卷10222期e27页

7869. ECHO: context and limitations.

作者: Britta L Jewell.;Jennifer A Smith.;Nancy S Padian.;Janneke H H M van de Wijgert.;Erica L Gollub.;Heidi E Jones.;Lauren J Ralph.;Timothy B Hallett.
来源: Lancet. 2020年395卷10222期e25-e26页

7870. ECHO: context and limitations.

作者: Erica L Gollub.;Zena Stein.;Janneke H H M van de Wijgert.;Heidi Jones.;Lauren Ralph.;Nancy Padian.
来源: Lancet. 2020年395卷10222期e24页

7871. ECHO: context and limitations.

作者: Jeanne Marrazzo.;Jennifer E Balkus.;Sharon Achilles.;Lisa Noguchi.
来源: Lancet. 2020年395卷10222期e23页

7872. ECHO: context and limitations.

作者: Janet P Hapgood.
来源: Lancet. 2020年395卷10222期e22页

7873. ECHO: context and limitations.

作者: Rodolfo D Vicetti Miguel.;Nirk E Quispe Calla.;Kristen M Aceves.;Fiorela C Dueñas Lopez.;Thomas L Cherpes.
来源: Lancet. 2020年395卷10222期e21页

7874. Points to consider regarding the SABR-COMET trial - Authors' reply.

作者: David A Palma.;Andrew Warner.;Suresh Senan.
来源: Lancet. 2020年395卷10222期e20页

7875. Points to consider regarding the SABR-COMET trial.

作者: Fergus Macbeth.;Tom Treasure.
来源: Lancet. 2020年395卷10222期e19页

7876. Facial filler causes stroke after development of cerebral fat embolism.

作者: Libin Liu.;Mingyu Yin.;Sanxin Liu.;Mengyan Hu.;Bingjun Zhang.
来源: Lancet. 2020年395卷10222期449页

7877. Plaster cast versus functional brace for non-surgical treatment of Achilles tendon rupture (UKSTAR): a multicentre randomised controlled trial and economic evaluation.

作者: Matthew L Costa.;Juul Achten.;Ioana R Marian.;Susan J Dutton.;Sarah E Lamb.;Benjamin Ollivere.;Mandy Maredza.;Stavros Petrou.;Rebecca S Kearney.; .
来源: Lancet. 2020年395卷10222期441-448页
Patients with Achilles tendon rupture who have non-operative treatment have traditionally been treated with immobilisation of the tendon in plaster casts for several weeks. Functional bracing is an alternative non-operative treatment that allows earlier mobilisation, but evidence on its effectiveness and safety is scarce. The aim of the UKSTAR trial was to compare functional and quality-of-life outcomes and resource use in patients treated non-operatively with plaster cast versus functional brace.

7878. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.

作者: Christopher T Ritchlin.;Arthur Kavanaugh.;Joseph F Merola.;Georg Schett.;Jose U Scher.;Richard B Warren.;Alice B Gottlieb.;Deepak Assudani.;Kathy Bedford-Rice.;Jason Coarse.;Barbara Ink.;Iain B McInnes.
来源: Lancet. 2020年395卷10222期427-440页
Dual neutralisation of interleukin 17A (IL17A) and interleukin 17F (IL17F) is a potential novel therapeutic approach in psoriatic arthritis. We assessed bimekizumab, a monoclonal antibody that selectively neutralises IL17A and IL17F, in patients with active psoriatic arthritis.

7879. Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial.

作者: .
来源: Lancet. 2020年395卷10222期417-426页
Closure of an abdominal stoma, a common elective operation, is associated with frequent complications; one of the commonest and impactful is incisional hernia formation. We aimed to investigate whether biological mesh (collagen tissue matrix) can safely reduce the incidence of incisional hernias at the stoma closure site.

7880. Perception of severity of adverse events in oral immunotherapy - Authors' reply.

作者: Derek K Chu.;Robert A Wood.;Shannon French.;Alessandro Fiocchi.;Susan Waserman.;Holger J Schünemann.; .
来源: Lancet. 2020年395卷10222期415-416页
共有 8124 条符合本次的查询结果, 用时 4.3163199 秒